Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NeuroPace (NPCE) Assets (2020 - 2025)

Historic Assets for NeuroPace (NPCE) over the last 6 years, with Q3 2025 value amounting to $107.3 million.

  • NeuroPace's Assets rose 1137.24% to $107.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $107.3 million, marking a year-over-year increase of 1137.24%. This contributed to the annual value of $94.6 million for FY2024, which is 1207.98% down from last year.
  • Per NeuroPace's latest filing, its Assets stood at $107.3 million for Q3 2025, which was up 1137.24% from $106.1 million recorded in Q2 2025.
  • NeuroPace's Assets' 5-year high stood at $147.0 million during Q2 2021, with a 5-year trough of $50.3 million in Q1 2021.
  • For the 5-year period, NeuroPace's Assets averaged around $109.3 million, with its median value being $107.3 million (2025).
  • Examining YoY changes over the last 5 years, NeuroPace's Assets showed a top increase of 15630.32% in 2022 and a maximum decrease of 1934.08% in 2022.
  • Quarter analysis of 5 years shows NeuroPace's Assets stood at $133.6 million in 2021, then decreased by 14.57% to $114.1 million in 2022, then dropped by 5.66% to $107.7 million in 2023, then fell by 12.08% to $94.6 million in 2024, then grew by 13.32% to $107.3 million in 2025.
  • Its last three reported values are $107.3 million in Q3 2025, $106.1 million for Q2 2025, and $110.2 million during Q1 2025.